Follow-up of cognitive impairment and inflammatory profile in individuals with mild COVID-19.
J Neuroimmunol
; 389: 578327, 2024 Apr 15.
Article
en En
| MEDLINE
| ID: mdl-38489978
ABSTRACT
Individuals who experience mild COVID-19 can suffer from long-lasting cognitive symptoms. Notably, 26% of these individuals experience difficulties with visuospatial abilities six months after infection. However, among those who initially exhibited visuoconstructive impairments, 66% showed improvement or complete reversal over time. Additionally, changes in cytokine levels, particularly CCL11, HGF, and CXCL10, were observed. These results suggest a potential link between ongoing cognitive issues and elevated levels of pro-inflammatory cytokines, which merits further investigation.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Disfunción Cognitiva
/
COVID-19
Límite:
Humans
Idioma:
En
Revista:
J Neuroimmunol
Año:
2024
Tipo del documento:
Article
País de afiliación:
Brasil